AU2001266219A1 - Novel process for preparing and harvesting crystalline particles - Google Patents

Novel process for preparing and harvesting crystalline particles

Info

Publication number
AU2001266219A1
AU2001266219A1 AU2001266219A AU6621901A AU2001266219A1 AU 2001266219 A1 AU2001266219 A1 AU 2001266219A1 AU 2001266219 A AU2001266219 A AU 2001266219A AU 6621901 A AU6621901 A AU 6621901A AU 2001266219 A1 AU2001266219 A1 AU 2001266219A1
Authority
AU
Australia
Prior art keywords
preparing
novel process
crystalline particles
harvesting
harvesting crystalline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001266219A
Other languages
English (en)
Inventor
Robert William Lancaster
Hardev Singh
Andrew Lewis Theophilus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2001266219A1 publication Critical patent/AU2001266219A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Vaporization, Distillation, Condensation, Sublimation, And Cold Traps (AREA)
AU2001266219A 2000-06-29 2001-06-29 Novel process for preparing and harvesting crystalline particles Abandoned AU2001266219A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0016040.8A GB0016040D0 (en) 2000-06-29 2000-06-29 Novel process for preparing crystalline particles
GB0016040 2000-06-29
PCT/GB2001/002923 WO2002000199A1 (en) 2000-06-29 2001-06-29 Novel process for preparing and harvesting crystalline particles

Publications (1)

Publication Number Publication Date
AU2001266219A1 true AU2001266219A1 (en) 2002-01-08

Family

ID=9894720

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001266219A Abandoned AU2001266219A1 (en) 2000-06-29 2001-06-29 Novel process for preparing and harvesting crystalline particles

Country Status (9)

Country Link
US (1) US20040045805A1 (es)
EP (1) EP1294360B1 (es)
JP (1) JP2004500984A (es)
AT (1) ATE306252T1 (es)
AU (1) AU2001266219A1 (es)
DE (1) DE60114002T2 (es)
ES (1) ES2248348T3 (es)
GB (1) GB0016040D0 (es)
WO (1) WO2002000199A1 (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6787532B2 (en) 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
GB0216700D0 (en) 2002-07-18 2002-08-28 Astrazeneca Ab Process
ITMI20022674A1 (it) * 2002-12-18 2004-06-19 Chiesi Farma Spa Procedimento per la preparazione di formulazioni sterili a base di principi attivi farmaceutici cristallini micronizzati da somministrare come sospensioni acquose per inalazione.
GB0302673D0 (en) 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
US7811606B2 (en) 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
US8912174B2 (en) * 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
US9808471B2 (en) 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
SE0302029D0 (sv) * 2003-07-07 2003-07-07 Astrazeneca Ab Novel process
ITMI20032054A1 (it) 2003-10-22 2005-04-23 Monteres S R L Processo per la preparazione di sospensioni farmaceutiche da inalare.
GB0406069D0 (en) * 2004-03-17 2004-04-21 Thompson James Process
FR2868789B1 (fr) * 2004-04-09 2008-09-26 Inst Francais Du Petrole Procede et dispositif de traitement d'une charge comportant du butadiene
EP1868577A4 (en) 2005-04-15 2009-12-09 Reddys Lab Inc Dr Lacidipine PARTICLE
EP1944018A1 (en) * 2007-01-10 2008-07-16 CHIESI FARMACEUTICI S.p.A. Micronised particles of low-dosage strength active agents for powder formulations for inhalation
GB0705159D0 (en) 2007-03-19 2007-04-25 Prosonix Ltd Process for making crystals
GB0711680D0 (en) * 2007-06-18 2007-07-25 Prosonix Ltd Process
PL2229148T3 (pl) * 2007-12-13 2014-08-29 Novartis Ag Sposób otrzymywania krystalicznych cząstek stałych substancji leczniczej
WO2010097188A1 (en) * 2009-02-25 2010-09-02 Chiesi Farmaceutici S.P.A. Inhalation particles comprising a salt of carmoterol and a corticosteroid
AU2011305567A1 (en) * 2010-09-22 2013-05-02 Map Pharmaceuticals, Inc. Corticosteroid particles and method of production
US8765725B2 (en) 2012-05-08 2014-07-01 Aciex Therapeutics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
EP2847207B1 (en) 2012-05-08 2019-03-27 Nicox Ophthalmics, Inc. Fluticasone propionate nanocrystals
EP2705838A1 (en) * 2012-09-06 2014-03-12 Xspray Microparticles Ab Tiotropium preparations
US9815865B2 (en) 2013-01-07 2017-11-14 Nicox Ophthalmics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
WO2014137982A1 (en) * 2013-03-08 2014-09-12 The Board Of Trustees Of The University Of Illinois Ultrasonic method and apparatus for producing particles having a controlled size distribution
PT107433B (pt) 2014-01-28 2018-12-04 Hovione Farm S A Processo de redução e controlo do tamanho de partícula
CN112933649A (zh) * 2021-02-03 2021-06-11 广西民族师范学院 一种用于化学药物的高效分离方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9501384D0 (sv) * 1995-04-13 1995-04-13 Astra Ab Process for the preparation of respirable particles
US5833891A (en) * 1996-10-09 1998-11-10 The University Of Kansas Methods for a particle precipitation and coating using near-critical and supercritical antisolvents
SE510666C2 (sv) * 1996-12-20 1999-06-14 Astra Ab Nya Kristallmodifikationer
MA26473A1 (fr) * 1997-03-01 2004-12-20 Glaxo Group Ltd Composes pharmacologiquement actifs.
GB9806477D0 (en) * 1998-03-26 1998-05-27 Glaxo Group Ltd Improved crystals
SE9804001D0 (sv) * 1998-11-23 1998-11-23 Astra Ab New process
SE9804003D0 (sv) * 1998-11-23 1998-11-23 Astra Ab A method of producing drug particles
GB9828721D0 (en) * 1998-12-24 1999-02-17 Glaxo Group Ltd Novel apparatus and process
EP1173265B1 (en) * 1999-01-29 2005-12-21 Bristol-Myers Squibb Company Sonic impinging jet crystallization apparatus and process

Also Published As

Publication number Publication date
DE60114002T2 (de) 2006-07-06
EP1294360B1 (en) 2005-10-12
DE60114002D1 (de) 2005-11-17
US20040045805A1 (en) 2004-03-11
ES2248348T3 (es) 2006-03-16
ATE306252T1 (de) 2005-10-15
EP1294360A1 (en) 2003-03-26
WO2002000199A1 (en) 2002-01-03
GB0016040D0 (en) 2000-08-23
JP2004500984A (ja) 2004-01-15

Similar Documents

Publication Publication Date Title
AU2001266219A1 (en) Novel process for preparing and harvesting crystalline particles
AU2001266218A1 (en) Process for preparing and harvesting crystalline particles
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
YU7804A (sh) Stabilni polimorf flibanserina,postupak za njegovo dobijanje u industrijskim razmerama i njegova primena za pripremanje lekova
AU2001267708A1 (en) Novel process for preparing crystalline particles
WO2003037863A3 (de) Substituierte indole, verfahren zu deren herstellung und deren verwendung zur schmerzbekämpfung
GB9907571D0 (en) Compounds
AU6578400A (en) Novel method for preparing benzoperhydroisoindole compounds
BG106002A (en) Process for preparing pesticidal intermediates
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
WO2001049651A3 (de) Aminomethyl-phenyl-cyclohexanonderivate
AU2002330042A1 (en) Process for the preparation of 1,5-diarylpyrazoles
MXPA02009210A (es) Modificacion amorfa de torasemida.
AU3822900A (en) Process for the treatment of fly ash, using hydrochloric acid
AU5419699A (en) Methoximinophenylacetic acid amides
AU2003244235A1 (en) Process for preparation of optically active 1-substituted amino-2,3-epoxypropanes, intermediates for the synthesis thereof and process for preparation of the intermediates
MY127328A (en) 5-amino-1-pentene-3-ol substituted derivatives
AU4950597A (en) Composition containing chitosan
AU5219700A (en) Halopyrimidines
AU1298800A (en) Process of preparing a high-energy softening agent
AU2910800A (en) Novel substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines
AU2002311623A1 (en) Process for the preparation of 1,4-dihydropyridines and novel 1,4-dihydropyridines useful as therapeutic agents
AU7728296A (en) Hemoregulatory compounds
AU2090900A (en) Novel gymnemic acid derivatives, process for the preparation thereof and use thereof as medicine
TW200407314A (en) Preparation of 4, 6-dichloro-5-fluoropyrimidine